Kalbe Farma Dividends and Buybacks
Dividend criteria checks 5/6
Kalbe Farma is a dividend paying company with a current yield of 2.11% that is well covered by earnings.
Key information
2.1%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 2.6% |
| Dividend Growth | 6.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €31.000 |
| Payout ratio | 46% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: LCLA's dividends per share have been stable in the past 10 years.
Growing Dividend: LCLA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Kalbe Farma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LCLA) | 2.1% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (LCLA) (up to 3 years) | 2.6% |
Notable Dividend: LCLA's dividend (2.11%) is higher than the bottom 25% of dividend payers in the German market (1.73%).
High Dividend: LCLA's dividend (2.11%) is low compared to the top 25% of dividend payers in the German market (4.82%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (46.4%), LCLA's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (39.9%), LCLA's dividend payments are well covered by cash flows.